A Milestone Anniversary in Bulgaria Our mission has always been to provide families worldwide with access to the most advanced regenerative medicine and cord blood banking technologies. This month, we are delighted to celebrate a significant milestone in that...
Key details High amputation risk: Diabetic foot ulcers are a serious complication of diabetes, often leading to infection and significantly higher amputation risks compared to the non-diabetic population. Treating the root cause: Unlike standard care, stem cell...
Key details Current limitations: Traditional scar treatments (surgery, gels, steroids) are often only partially effective. Even after treatment, scars frequently remain, presenting aesthetic and functional challenges for patients. New research: A recent review...
Key details New clinical phase: A stem cell therapy called laromestrocel has entered a pivotal Phase 2b clinical trial to treat hypoplastic left heart syndrome (HLHS), a congenital defect where the left heart is severely undeveloped.[1] Standard of care: Treatment for...
Key details Current treatment limitations: While ischaemic strokes – which account for nearly 90% of all strokes – are currently treated with clot removal and supportive rehabilitation, there remains a significant unmet need for therapies that directly address...
Key details New trial approval: The South Korean Ministry of Food and Drug Safety has approved a Phase 2a trial for a new umbilical cord stem cell therapy to treat Charcot-Marie-Tooth disease (CMT), one of the most commonly inherited nerve diseases.[1] Promising phase...
